cytidine diphosphate choline has been researched along with Disease Models, Animal in 67 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.49) | 18.7374 |
1990's | 2 (2.99) | 18.2507 |
2000's | 24 (35.82) | 29.6817 |
2010's | 32 (47.76) | 24.3611 |
2020's | 8 (11.94) | 2.80 |
Authors | Studies |
---|---|
Bakulin, DA; Kovalenko, AL; Kurkin, DV; Kuznetsova, EV; Lycheva, NA; Morkovin, EI; Myagkova, IA; Robertus, AI; Shmidt, MV; Tarasov, AS | 1 |
Chen, Q; Gao, Y; Guo, L; Jiang, H; Xu, M; Zhang, F; Zhou, F | 1 |
Chen, J; Chen, Y; Fang, M; Feng, X; Xiao, C; Zhang, M | 1 |
Jasielski, P; Petit, V; Piędel, F; Piwek, M; Rejdak, K; Rocka, A | 1 |
Candiotti, KA; Gitlin, MC; Sevilla, A; Wang, S; Weller, R; Zhang, Y | 1 |
Amin, SN; El Gazzar, WB; Hussein, UK; Khashaba, AS; Latif, NSA | 1 |
Khakpai, F; Ramezanikhah, M; Valizadegan, F; Zarrindast, MR | 1 |
Partadiredja, G; Yuliani, S | 1 |
Choi, BY; Choi, MG; Hong, DK; Jeong, JH; Kho, AR; Kim, JH; Lee, SH; Ryu, OH; Sohn, M; Suh, SW | 1 |
Aranda-Frausto, A; Bojalil, R; Buelna-Chontal, M; Correa, F; Galvan Arzate, S; González-Pacheco, H; Macías-López, A; Pavón, N; Román-Anguiano, NG; Silva-Palacios, A; Springall, R; Velázquez-Espejel, R; Zazueta, C | 1 |
Akhondzadeh, S; Nejatisafa, AA; Roohi-Azizi, M; Sadat-Shirazi, MS; Torkaman-Boutorabi, A; Zarrindast, MR | 1 |
Baba, T; Bikbova, G; Kitamura, Y; Oshitari, T; Yamamoto, S | 1 |
Fukunaga, K; Hishida, Y; Izumi, H; Kamimura, A; Nakazaki, E; Shinoda, Y; Watanabe, F; Yabuki, Y | 1 |
Beaumont, E; Rouleau, DM; Wang, L | 1 |
Canpolat, FE; Cansev, M; Cekmez, F; Cetinkaya, M; Kafa, IM; Sarici, SU; Tayman, C; Tunc, T | 1 |
Centofanti, M; Manni, G; Parisi, V; Roberti, G; Sampalmieri, M; Tanga, L | 1 |
Borlongan, CV; Coll-Andreu, M; Costa-Miserachs, D; Jacotte-Simancas, A; Portell-Cortés, I; Torras-Garcia, M | 1 |
Choi, BY; Choi, HC; Kim, JH; Lee, DW; Lee, SH; Sohn, M; Song, HK; Suh, SW | 1 |
Brenner, T; Doerr, M; Hernekamp, JF; Hofer, S; Schmidt, K; Walther, A; Weigand, MA; Zivkovic, AR | 1 |
Karpova, MN; Klishina, NV; Kuznetsova, LV; Zin'kovskii, KA | 1 |
Fu, C; Liu, S; Mao, J | 1 |
Bulte, JW; Cao, S; Chen, H; Jablonska, A; Janowski, M; Li, Y; Liu, D; Liu, G; Liu, H; Van Zijl, PC; Walczak, P | 1 |
Fiedorowicz, M; Grieb, P; Makarewicz, D; Stańczak-Mrozek, KI | 1 |
Eisenach, JC; Gurun, MS; Parker, R; Vincler, M | 1 |
Cox, GA; Sher, RB; Vance, DE; Wu, G | 1 |
Alkan, T; Korfali, E; Sahin, S; Temel, SG; Tolunay, S; Tureyen, K | 1 |
Menku, A; Ogden, M; Saraymen, R | 1 |
Botsina, AIu; Shamalov, NA; Shetova, IM | 1 |
Díez-Tejedor, E; Frank-García, A; García-Cobos, R; Gutiérrez-Fernández, M | 1 |
Das, N; Dungdung, SR; Ghosh, S; Mandal, AK; Sarkar, S | 1 |
Agulla, J; Argibay, B; Castillo, J; Pérez-Mato, M; Ramos-Cabrer, P | 1 |
Fujikawa, R; Fujiwara, M; Iwasaki, K; Katsurabayashi, S; Kawasaki, C; Kubota, K; Mishima, K; Morishita, K; Morita, M; Nakamura, K; Nogami, A; Takasaki, K; Uchida, K; Yamaguchi, K | 1 |
Chaba, T; Jacobs, RL; Niebergall, LJ; Vance, DE | 1 |
Aslan, E; Bekar, A; Kocaeli, H; Tolunay, S; Ulus, IH | 1 |
Bagdas, D; Gurun, MS; Hamurtekin, E; Sonal, S; Sonat, FA | 1 |
Bekar, A; Caner, B; Cansev, M; Kafa, MI; Karli, N; Kurt, MA; Ulus, IH | 1 |
Altach, E; Diederich, K; Eggert, V; Frauenknecht, K; Minnerup, J; Schäbitz, WR; Schmidt, A; Schneider, BK; Sommer, CJ | 1 |
Díez-Tejedor, E; Gutiérrez-Fernández, M; Leciñana, MA; Ramos-Cejudo, J; Roda, JM; Rodríguez-Frutos, B | 1 |
Bustamante, A; Campos, M; Garcia-Bonilla, L; Giralt, D; Montaner, J; Rosell, A | 1 |
Canpolat, FE; Cansev, M; Cekmez, F; Cetinkaya, M; Kafa, IM; Sarici, SU; Tayman, C; Tunc, T; Uysal, S | 1 |
Dengler, R; Gudi, V; Knippenberg, S; Körner, S; Petri, S; Pul, R; Rath, KJ; Skripuletz, T; Stangel, M; Thau, N | 1 |
Adibhatla, RM; Hatcher, JF | 1 |
Dempsey, RJ; Raghavendra Rao, VL | 1 |
Teather, LA; Wurtman, RJ | 1 |
Ataus, SA; Balkan, S; Locke, KW; Onal, MZ; Ozdem, SS | 1 |
Cárdenas, A; Castillo, J; Dávalos, A; Fernández-Tomé, P; Hurtado, O; Leza, JC; Lizasoain, I; Lorenzo, P; Lozano, R; Moro, MA; Sánchez, V; Secades, JJ | 1 |
Adibhatla, RM; Hatcher, JF; Tureyen, K | 1 |
Alver, A; Baykal, S; Cakir, E; Kuzeyli, K; Peksoylu, B; Sayin, OC; Topbas, M; Usul, H | 1 |
Alonso de Leciñana, M; Carceller, F; Díez Tejedor, E; Fuentes, B; Gutiérrez, M; Roda, JM | 1 |
Meden, P; Overgaard, K | 1 |
Alonso de Leciñana, M; Carceller, F; Díez-Tejedor, E; Gutiérrez, M; Roda, JM | 1 |
Bolz, S; Grieb, P; Junemann, A; Lehaci, C; Mankowska, A; Rejdak, R; Schuettauf, F; Thaler, S; Zagorski, Z; Zarnowski, T; Zrenner, E | 1 |
Gurun, MS; Hamurtekin, E | 1 |
Blum, D; Brotchi, J; Ledent, C; Levivier, M; Mievis, S; Vassart, G | 1 |
Bagdas, D; Gurun, MS; Hamurtekin, E | 1 |
Deutsch, SI; Gaskins, BL; Long, KD; Mastropaolo, J; Rosse, RB; Schooler, NR; Schwartz, BL | 1 |
Alborch, E; Castillo, J; Fernández-López, D; Hurtado, O; Lizasoain, I; Morales, JR; Moro, MA; Pradillo, JM; Sobrino, T | 1 |
Bekar, A; Filiz, G; Karlı, N; Kocaeli, H; Özay, R; Ulus, IH | 1 |
Cansev, M; Hamurtekin, E; Ilcol, YO; Ulus, IH; Yilmaz, MS | 1 |
Di Giacomo, C; Fresta, M; Puglisi, G; Russo, A | 1 |
Fisher, M; Locke, KW; Sandage, BW; Schäbitz, WR; Takano, K; Weber, J | 1 |
Blusztajn, JK; Farber, SA; Slack, BE | 1 |
Dempsey, RJ; Hatcher, JF; Rao, AM | 1 |
Adibhatla, RM; Dempsey, RJ; Hatcher, JF | 1 |
Dodd, RC; Havener, LJ; Spargo, BH; Toback, FG | 1 |
Braisted, J; Dranchak, P; Earnest, TW; Gu, X; Hoon, MA; Inglese, J; Oliphant, E; Solinski, HJ | 1 |
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
7 review(s) available for cytidine diphosphate choline and Disease Models, Animal
Article | Year |
---|---|
Application of Citicoline in Neurological Disorders: A Systematic Review.
Topics: Animals; Brain Injuries, Traumatic; Cognition; Cytidine Diphosphate Choline; Dementia; Disease Models, Animal; Humans; Meta-Analysis as Topic; Nervous System Diseases; Neuralgia; Neurotransmitter Agents; Peripheral Nervous System; Stroke | 2020 |
Most effective adjuvant treatments after surgery in peripheral nerve laceration: Systematic review of the literature on rodent models.
Topics: Animals; Cytidine Diphosphate Choline; Disease Models, Animal; Humans; Lacerations; Nerve Growth Factors; Nitric Oxide Synthase; Peripheral Nerves; Rodentia; Treatment Outcome | 2013 |
[The use of citicoline in the acute cerebral stroke].
Topics: Animals; Cytidine Diphosphate Choline; Disease Models, Animal; Humans; Neuroprotective Agents; Stroke | 2009 |
Citicoline, use in cognitive decline: vascular and degenerative.
Topics: Animals; Cognition Disorders; Cytidine Diphosphate Choline; Dementia; Disease Models, Animal; Humans; Nootropic Agents | 2010 |
Citicoline in pre-clinical animal models of stroke: a meta-analysis shows the optimal neuroprotective profile and the missing steps for jumping into a stroke clinical trial.
Topics: Animals; Clinical Trials as Topic; Cytidine Diphosphate Choline; Disease Models, Animal; Humans; Neuroprotective Agents; Nootropic Agents; Stroke | 2012 |
Citicoline mechanisms and clinical efficacy in cerebral ischemia.
Topics: Animals; Arachidonic Acid; Brain Ischemia; Clinical Trials as Topic; Cytidine Diphosphate Choline; Disease Models, Animal; Humans; Ischemic Attack, Transient; Neuroprotective Agents; Phosphatidylcholines; Phospholipases A; Rats; Treatment Outcome | 2002 |
Citicoline--the first effective neuroprotectant to be combined with thrombolysis in acute ischemic stroke?
Topics: Animals; Clinical Trials as Topic; Cytidine Diphosphate Choline; Disease Models, Animal; Drug Therapy, Combination; Humans; Neuroprotective Agents; Stroke; Thrombolytic Therapy | 2006 |
60 other study(ies) available for cytidine diphosphate choline and Disease Models, Animal
Article | Year |
---|---|
[Study of the effect of Unifuzol on cognitive impairment and damage to the hippocampus and cerebral cortex during course administration to rats with bilateral stenosis of the common carotid arteries, causing chronic circulatory failure].
Topics: Animals; Brain Ischemia; Carotid Artery, Common; Carotid Stenosis; Cognitive Dysfunction; Constriction, Pathologic; Cytidine Diphosphate Choline; Disease Models, Animal; Hippocampus; Male; Nicergoline; Rats; Shock | 2023 |
CDP-choline modulates cholinergic signaling and gut microbiota to alleviate DSS-induced inflammatory bowel disease.
Topics: Acetylcholine; Acetylcholinesterase; Animals; Choline; Colitis; Colon; Cytidine Diphosphate Choline; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Microbiome; Humans; Inflammation; Inflammatory Bowel Diseases; Mice; Mice, Inbred C57BL; Nicotinic Antagonists | 2023 |
Protective effect of citicoline on random flap survival in a rat mode.
Topics: Animals; Anti-Inflammatory Agents; Cytidine Diphosphate Choline; Cytokines; Disease Models, Animal; Graft Survival; Humans; Inflammation Mediators; Male; NF-kappa B; Plastic Surgery Procedures; Rats; Rats, Sprague-Dawley; Signal Transduction; Skin Transplantation; Surgical Flaps; Toll-Like Receptor 4; Vascular Endothelial Growth Factor A | 2020 |
The role of α7-nicotinic acetylcholine receptor in a rat model of chronic nicotine-induced mechanical hypersensitivity.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Chronic Pain; Cytidine Diphosphate Choline; Disease Models, Animal; Hyperalgesia; Male; Nicotine; Nootropic Agents; Rats; Rats, Sprague-Dawley; Spinal Cord; Touch | 2021 |
Citicoline improved cardiovascular function in animal model of dysautonomia.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Blood Pressure; Cardiovascular Diseases; Cytidine Diphosphate Choline; Disease Models, Animal; Echocardiography; Electrocardiography; Male; Mitochondria; Primary Dysautonomias; Rats | 2021 |
Synergistic effect between imipramine and citicoline upon induction of analgesic and antidepressant effects in mice.
Topics: Analgesics; Animals; Antidepressive Agents, Tricyclic; Cytidine Diphosphate Choline; Depression; Disease Models, Animal; Drug Synergism; Humans; Imipramine; Injections, Intraperitoneal; Male; Mice; Nociception; Pain | 2021 |
Turmeric (Curcuma longa L.) extract may prevent the deterioration of spatial memory and the deficit of estimated total number of hippocampal pyramidal cells of trimethyltin-exposed rats.
Topics: Animals; Behavior, Animal; Curcuma; Cytidine Diphosphate Choline; Disease Models, Animal; Hippocampus; Male; Maze Learning; Memory Disorders; Nerve Degeneration; Neuroprotective Agents; Nootropic Agents; Phytotherapy; Plant Extracts; Plants, Medicinal; Pyramidal Cells; Rats, Sprague-Dawley; Reactive Nitrogen Species; Reactive Oxygen Species; Rhizome; Spatial Memory; Time Factors; Trimethyltin Compounds | 2018 |
Acetylcholine precursor, citicoline (cytidine 5'-diphosphocholine), reduces hypoglycaemia-induced neuronal death in rats.
Topics: Animals; Cell Death; Cytidine Diphosphate Choline; Disease Models, Animal; Hypoglycemia; Insulin; Male; Microglia; Neurons; Neuroprotective Agents; Nootropic Agents; Oxidative Stress; Rats; Rats, Sprague-Dawley | 2018 |
Cytidine-5'-Diphosphocholine Protects the Liver From Ischemia/Reperfusion Injury Preserving Mitochondrial Function and Reducing Oxidative Stress.
Topics: Animals; Cytidine Diphosphate Choline; Disease Models, Animal; Humans; Liver; Liver Function Tests; Liver Transplantation; Male; Mitochondria; Oxidative Stress; Protective Agents; Rats; Rats, Wistar; Reactive Oxygen Species; Reperfusion Injury | 2018 |
Influence of citicoline on citalopram-induced antidepressant activity in depressive-like symptoms in male mice.
Topics: Animals; Antidepressive Agents; Chemotherapy, Adjuvant; Citalopram; Cytidine Diphosphate Choline; Depression; Depressive Disorder; Disease Models, Animal; Dose-Response Relationship, Drug; Feeding Behavior; Male; Mice; Motor Activity; Random Allocation; Stress, Psychological | 2018 |
In vivo effects of single or combined topical neuroprotective and regenerative agents on degeneration of retinal ganglion cells in rat optic nerve crush model.
Topics: Administration, Topical; Animals; Cell Count; Cytidine Diphosphate Choline; Disease Models, Animal; Drug Therapy, Combination; Histocytochemistry; Immunohistochemistry; Nerve Growth Factors; Neuroprotective Agents; Optic Nerve Injuries; Rats, Sprague-Dawley; Retinal Ganglion Cells; Taurochenodeoxycholic Acid; Treatment Outcome | 2019 |
Combined citicoline and docosahexaenoic acid treatment improves cognitive dysfunction following transient brain ischemia.
Topics: Animals; Avoidance Learning; Brain Ischemia; CA1 Region, Hippocampal; Cell Survival; Cognitive Dysfunction; Cytidine Diphosphate Choline; Disease Models, Animal; Docosahexaenoic Acids; Drug Therapy, Combination; Learning; Male; Memory; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Recognition, Psychology; Treatment Outcome | 2019 |
Cytidine 5'-diphosphocholine ameliorates hyperoxic lung injury in a neonatal rat model.
Topics: Animals; Animals, Newborn; Cytidine Diphosphate Choline; Disease Models, Animal; Hyperoxia; Lung Injury; Rats | 2013 |
A preliminary study of the neuroprotective role of citicoline eye drops in glaucomatous optic neuropathy.
Topics: Animals; Cytidine Diphosphate Choline; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Electroretinography; Glaucoma, Open-Angle; Mice; Nootropic Agents; Ophthalmic Solutions; Optic Nerve Diseases; Retinal Ganglion Cells | 2014 |
Effects of voluntary physical exercise, citicoline, and combined treatment on object recognition memory, neurogenesis, and neuroprotection after traumatic brain injury in rats.
Topics: Animals; Behavior, Animal; Brain Injuries; Combined Modality Therapy; Cytidine Diphosphate Choline; Disease Models, Animal; Male; Memory, Long-Term; Memory, Short-Term; Motor Activity; Neurogenesis; Neuroprotection; Nootropic Agents; Rats; Rats, Sprague-Dawley; Recognition, Psychology | 2015 |
Cytidine 5'-diphosphocholine (CDP-choline) adversely effects on pilocarpine seizure-induced hippocampal neuronal death.
Topics: Animals; Blood-Brain Barrier; CD11b Antigen; Cell Death; Cytidine Diphosphate Choline; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Epilepsy, Temporal Lobe; Excitatory Amino Acid Agonists; Fluoresceins; Hippocampus; Kainic Acid; Male; Microglia; Neurons; Nootropic Agents; Pilocarpine; Rats; Rats, Sprague-Dawley | 2015 |
Cytidine-5-diphosphocholine reduces microvascular permeability during experimental endotoxemia.
Topics: Animals; Capillary Permeability; Cell Adhesion; Cytidine Diphosphate Choline; Disease Models, Animal; Endotoxemia; Leukocytes; Lipopolysaccharides; Male; Nootropic Agents; Rats; Rats, Wistar; Sepsis | 2015 |
Anticonvulsant Effects of Combined Treatment with Citicoline and Valproate on the Model of Acute Generalized Convulsions Induced by Pentylenetetrazole in Wistar Rats.
Topics: Animals; Anticonvulsants; Cytidine Diphosphate Choline; Disease Models, Animal; Drug Therapy, Combination; Male; Nootropic Agents; Pentylenetetrazole; Rats; Rats, Wistar; Seizures; Valproic Acid | 2016 |
Citicoline retards myopia progression following form deprivation in guinea pigs.
Topics: Animals; Cytidine Diphosphate Choline; Disease Models, Animal; Dopamine; Guinea Pigs; Myopia; Nootropic Agents; Retina; Sensory Deprivation | 2016 |
Label-free CEST MRI Detection of Citicoline-Liposome Drug Delivery in Ischemic Stroke.
Topics: Animals; Brain; Cytidine Diphosphate Choline; Disease Models, Animal; Drug Carriers; Injections, Intra-Articular; Liposomes; Magnetic Resonance Imaging; Nootropic Agents; Rats; Stroke | 2016 |
CDP-choline (citicoline) attenuates brain damage in a rat model of birth asphyxia.
Topics: Animals; Animals, Newborn; Apoptosis; Asphyxia Neonatorum; Carrier Proteins; Caspase 3; Cytidine Diphosphate Choline; Disease Models, Animal; Dose-Response Relationship, Drug; Female; HSP70 Heat-Shock Proteins; Humans; Hypoxia-Ischemia, Brain; Infant, Newborn; Male; Microfilament Proteins; Neuroprotective Agents; Nootropic Agents; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar | 2008 |
The effect of peripherally administered CDP-choline in an acute inflammatory pain model: the role of alpha7 nicotinic acetylcholine receptor.
Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Analgesics; Animals; Anti-Inflammatory Agents; Carrageenan; Cytidine Diphosphate Choline; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Inflammation; Injections; Male; Nicotinic Agonists; Nicotinic Antagonists; Pain; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Time Factors; Tumor Necrosis Factor-alpha | 2009 |
Differential expression of choline kinase isoforms in skeletal muscle explains the phenotypic variability in the rostrocaudal muscular dystrophy mouse.
Topics: Animals; Cardiotoxins; Choline Kinase; Choline-Phosphate Cytidylyltransferase; Cytidine Diphosphate Choline; Disease Models, Animal; Forelimb; Hindlimb; Homeostasis; Isoenzymes; Mice; Mice, Knockout; Mitochondria; Muscle, Skeletal; Muscular Dystrophy, Animal; Phenotype; Phosphatidylcholines; Regeneration | 2010 |
Effects of citicoline used alone and in combination with mild hypothermia on apoptosis induced by focal cerebral ischemia in rats.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Biomarkers; Brain; Brain Infarction; Brain Ischemia; Combined Modality Therapy; Cytidine Diphosphate Choline; Disease Models, Animal; Hypothermia, Induced; Immunohistochemistry; Infarction, Middle Cerebral Artery; Male; Nerve Degeneration; Neurons; Neuroprotective Agents; Nootropic Agents; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Treatment Outcome | 2010 |
The protective effects of propofol and citicoline combination in experimental head injury in rats.
Topics: Animals; Blood Pressure; Craniocerebral Trauma; Cytidine Diphosphate Choline; Disease Models, Animal; Drug Therapy, Combination; Heart Rate; Lipid Peroxidation; Neuroprotective Agents; Nootropic Agents; Propofol; Rats; Superoxide Dismutase | 2010 |
Mannosylated liposomal cytidine 5' diphosphocholine prevent age related global moderate cerebral ischemia reperfusion induced mitochondrial cytochrome c release in aged rat brain.
Topics: Aging; Analysis of Variance; Animals; Brain; Brain Ischemia; Catalase; Cytidine Diphosphate Choline; Cytochromes c; Disease Models, Animal; Glutathione; Lipid Peroxidation; Liposomes; Male; Mannose; Microscopy, Electron, Transmission; Mitochondria; Nootropic Agents; Rats; Rats, Wistar; Reperfusion; Statistics as Topic; Superoxide Dismutase | 2010 |
Serial MRI study of the enhanced therapeutic effects of liposome-encapsulated citicoline in cerebral ischemia.
Topics: Animals; Brain; Brain Ischemia; Cerebral Infarction; Cytidine Diphosphate Choline; Disease Models, Animal; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; Injections, Intraperitoneal; Injections, Intravenous; Liposomes; Magnetic Resonance Imaging; Male; Nootropic Agents; Rats; Rats, Sprague-Dawley; Stroke | 2011 |
Neuroprotective effects of citidine-5-diphosphocholine on impaired spatial memory in a rat model of cerebrovascular dementia.
Topics: Animals; Cytidine Diphosphate Choline; Disease Models, Animal; Male; Maze Learning; Memory Disorders; Neuroprotective Agents; Rats; Rats, Wistar | 2011 |
Phosphatidylcholine protects against steatosis in mice but not non-alcoholic steatohepatitis.
Topics: Adenoviridae; Animals; Betaine; Ceramides; Choline-Phosphate Cytidylyltransferase; Cytidine Diphosphate Choline; Diet, High-Fat; Disease Models, Animal; Fatty Liver; Female; Genetic Predisposition to Disease; Genetic Vectors; Lipotropic Agents; Liver; Mice; Mice, Inbred C57BL; Mice, Knockout; Non-alcoholic Fatty Liver Disease; Phosphatidylcholines; Triglycerides | 2011 |
CDP-choline and its endogenous metabolites, cytidine and choline, promote the nerve regeneration and improve the functional recovery of injured rat sciatic nerves.
Topics: Administration, Cutaneous; Animals; Choline; Cytidine; Cytidine Diphosphate Choline; Disease Models, Animal; Female; Nerve Regeneration; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Recovery of Function; Sciatic Neuropathy; Trauma Severity Indices | 2011 |
The antihyperalgesic effect of cytidine-5'-diphosphate-choline in neuropathic and inflammatory pain models.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Analgesics; Animals; Choline; Cytidine Diphosphate Choline; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperalgesia; Inflammation; Male; Neuralgia; Pain; Rats; Rats, Sprague-Dawley; Receptors, GABA-B; Receptors, Nicotinic; Receptors, Opioid; Time Factors | 2011 |
Intraperitoneal administration of CDP-choline or a combination of cytidine plus choline improves nerve regeneration and functional recovery in a rat model of sciatic nerve injury.
Topics: Animals; Axotomy; Choline; Cytidine; Cytidine Diphosphate Choline; Disease Models, Animal; Drug Therapy, Combination; Female; Injections, Intraperitoneal; Nerve Regeneration; Nootropic Agents; Rats; Rats, Sprague-Dawley; Recovery of Function; Sciatic Nerve; Sciatic Neuropathy | 2012 |
Citicoline enhances neuroregenerative processes after experimental stroke in rats.
Topics: Animals; Cytidine Diphosphate Choline; Disease Models, Animal; Male; Neurogenesis; Neuroprotective Agents; Random Allocation; Rats; Rats, Wistar; Stroke | 2012 |
CDP-choline at high doses is as effective as i.v. thrombolysis in experimental animal stroke.
Topics: Animals; Cytidine Diphosphate Choline; Disease Models, Animal; Infusions, Intravenous; Male; Nootropic Agents; Random Allocation; Rats; Rats, Long-Evans; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome | 2012 |
CDP-choline reduces severity of intestinal injury in a neonatal rat model of necrotizing enterocolitis.
Topics: Animals; Animals, Newborn; Apoptosis; Cytidine Diphosphate Choline; Cytokines; Disease Models, Animal; Drug Evaluation, Preclinical; Enterocolitis, Necrotizing; Intestines; Nootropic Agents; Rats | 2013 |
CDP-choline is not protective in the SOD1-G93A mouse model of ALS.
Topics: Amyotrophic Lateral Sclerosis; Animals; Cytidine Diphosphate Choline; Disease Models, Animal; Female; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neuroprotective Agents; Random Allocation; Superoxide Dismutase | 2013 |
Cytidinediphosphocholine treatment to decrease traumatic brain injury-induced hippocampal neuronal death, cortical contusion volume, and neurological dysfunction in rats.
Topics: Animals; Brain Injuries; Cell Death; Cytidine Diphosphate Choline; Disease Models, Animal; Hippocampus; Male; Neurons; Nootropic Agents; Phospholipases; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 2003 |
Dietary cytidine (5')-diphosphocholine supplementation protects against development of memory deficits in aging rats.
Topics: Administration, Oral; Aging; Animals; Cytidine Diphosphate Choline; Diet; Disease Models, Animal; Female; Hippocampus; Memory Disorders; Nootropic Agents; Rats; Rats, Sprague-Dawley | 2003 |
The effects of citicoline and lamotrigine alone and in combination following permanent middle cerebral artery occlusion in rats.
Topics: Analysis of Variance; Animals; Anticonvulsants; Brain; Brain Ischemia; Cerebral Infarction; Cytidine Diphosphate Choline; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Therapy, Combination; Infarction, Middle Cerebral Artery; Lamotrigine; Male; Neurologic Examination; Random Allocation; Rats; Rats, Wistar; Statistics, Nonparametric; Tetrazolium Salts; Treatment Outcome; Triazines | 2004 |
Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport.
Topics: Adenosine Triphosphate; Amino Acid Transport System X-AG; Animals; Animals, Newborn; Astrocytes; Biological Transport; Brain; Brain Ischemia; Cell Survival; Cells, Cultured; Cerebral Infarction; Coculture Techniques; Cytidine Diphosphate Choline; Cytoprotection; Disease Models, Animal; Excitatory Amino Acid Transporter 2; Glutamate Plasma Membrane Transport Proteins; Glutamic Acid; L-Lactate Dehydrogenase; Male; Nerve Degeneration; Neurons; Neuroprotective Agents; Rats; Rats, Inbred F344; Rats, Wistar; Symporters | 2005 |
CDP-choline liposomes provide significant reduction in infarction over free CDP-choline in stroke.
Topics: Animals; Brain; Brain Infarction; Brain Ischemia; Cholesterol; Choline; Cytidine Diphosphate Choline; Disease Models, Animal; Drug Combinations; Drug Synergism; G(M1) Ganglioside; Liposomes; Male; Phagocytosis; Phosphatidylcholines; Rats; Rats, Inbred SHR; Reperfusion Injury; Stroke; Treatment Outcome | 2005 |
Effects of citicoline on experimental spinal cord injury.
Topics: Animals; Cytidine Diphosphate Choline; Disease Models, Animal; Lipid Peroxidation; Malondialdehyde; Motor Activity; Nootropic Agents; Rats; Rats, Wistar; Recovery of Function; Spinal Cord Injuries; Thiobarbituric Acid Reactive Substances | 2005 |
Thrombolysis and neuroprotection in cerebral ischemia.
Topics: Animals; Brain; Brain Ischemia; Clinical Trials as Topic; Cytidine Diphosphate Choline; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Neuroprotective Agents; Rats; Recombinant Proteins; Stroke; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator | 2006 |
Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke.
Topics: Animals; Brain Infarction; Cell Death; Cytidine Diphosphate Choline; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Fibrinolytic Agents; Immunohistochemistry; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Interleukin-6; Male; Neurologic Examination; Neuroprotective Agents; Rats; Rats, Long-Evans; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Tumor Necrosis Factor-alpha | 2006 |
Citicoline and lithium rescue retinal ganglion cells following partial optic nerve crush in the rat.
Topics: Animals; Apoptosis; Cell Count; Cytidine Diphosphate Choline; Disease Models, Animal; Female; Immunohistochemistry; Lithium; Microscopy, Fluorescence; Neuroprotective Agents; Optic Nerve Injuries; Pharmaceutical Vehicles; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Inbred BN; Retinal Ganglion Cells | 2006 |
The antinociceptive effects of centrally administered CDP-choline on acute pain models in rats: the involvement of cholinergic system.
Topics: Acetylcholine; Acute Disease; alpha7 Nicotinic Acetylcholine Receptor; Analgesics; Animals; Brain; Cholinergic Fibers; Cytidine Diphosphate Choline; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Injections, Intraventricular; Male; Neurotransmitter Uptake Inhibitors; Nicotinic Antagonists; Nociceptors; Pain; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Synaptic Transmission | 2006 |
Citicoline is not protective in experimental models of Huntington's disease.
Topics: Animals; Behavior, Animal; Cytidine Diphosphate Choline; Disease Models, Animal; Huntington Disease; Neuroprotective Agents; Nootropic Agents; Rats; Treatment Outcome | 2007 |
Possible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in rats.
Topics: Acute Disease; Adrenergic alpha-Antagonists; Analgesics; Animals; Brain; Cytidine Diphosphate Choline; Disease Models, Animal; Efferent Pathways; GABA Antagonists; Injections, Intraventricular; Male; Narcotic Antagonists; Nociceptors; Pain; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, GABA; Receptors, GABA-B; Receptors, Opioid; Receptors, Serotonin; Serotonin Antagonists | 2007 |
Effects of CDP-choline and the combination of CDP-choline and galantamine differ in an animal model of schizophrenia: development of a selective alpha7 nicotinic acetylcholine receptor agonist strategy.
Topics: Analysis of Variance; Animals; Behavior, Animal; Cholinesterase Inhibitors; Cytidine Diphosphate Choline; Disease Models, Animal; Dizocilpine Maleate; Drug Interactions; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Galantamine; Male; Mice; Nootropic Agents; Schizophrenia | 2008 |
Delayed post-ischemic administration of CDP-choline increases EAAT2 association to lipid rafts and affords neuroprotection in experimental stroke.
Topics: Animals; Cell Fractionation; Cytidine Diphosphate Choline; Disease Models, Animal; Excitatory Amino Acid Transporter 2; Gene Expression Regulation; Glutamic Acid; Infarction, Middle Cerebral Artery; Male; Membrane Microdomains; Neuroprotective Agents; Rats; Rats, Inbred F344; Time Factors | 2008 |
Citicoline improves functional recovery, promotes nerve regeneration, and reduces postoperative scarring after peripheral nerve surgery in rats.
Topics: Animals; Axons; Cicatrix; Connective Tissue; Cytidine Diphosphate Choline; Disease Models, Animal; Electromyography; Female; Nerve Regeneration; Nootropic Agents; Postoperative Complications; Rats; Rats, Sprague-Dawley; Recovery of Function; Sciatic Nerve | 2007 |
Peripheral administration of CDP-choline, phosphocholine or choline increases plasma adrenaline and noradrenaline concentrations.
Topics: Adrenal Glands; Animals; Atropine Derivatives; Autonomic Nervous System; Central Nervous System; Choline; Cytidine; Cytidine Diphosphate Choline; Cytidine Monophosphate; Disease Models, Animal; Dose-Response Relationship, Drug; Epinephrine; Female; Hemorrhage; Hexamethonium; Injections, Intraperitoneal; Injections, Intraventricular; Mecamylamine; Nicotinic Antagonists; Norepinephrine; Phosphorylcholine; Rats; Rats, Wistar; Time Factors | 2008 |
Liposomes as in-vivo carriers for citicoline: effects on rat cerebral post-ischaemic reperfusion.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Blood-Brain Barrier; Brain Ischemia; Cerebral Cortex; Cholesterol; Chromatography, High Pressure Liquid; Cytidine Diphosphate Choline; Disease Models, Animal; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Evaluation; Lactates; Lactic Acid; Lipid Peroxidation; Liposomes; Male; Phosphatidylserines; Rats; Rats, Wistar; Reperfusion Injury; Survival Rate | 1994 |
The effects of prolonged treatment with citicoline in temporary experimental focal ischemia.
Topics: Animals; Arterial Occlusive Diseases; Brain Diseases; Cerebral Arteries; Cerebral Infarction; Cytidine Diphosphate Choline; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Edema; Ischemic Attack, Transient; Male; Nootropic Agents; Rats; Rats, Sprague-Dawley; Survival Rate; Treatment Outcome | 1996 |
Acceleration of phosphatidylcholine synthesis and breakdown by inhibitors of mitochondrial function in neuronal cells: a model of the membrane defect of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Choline; Cytidine Diphosphate Choline; Dinitrophenols; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glycerylphosphorylcholine; Membranes; Mitochondria; Neurons; PC12 Cells; Phosphatidylcholines; Phosphorylcholine; Rats; Sodium Azide; Time Factors; Uncoupling Agents | 2000 |
Does CDP-choline modulate phospholipase activities after transient forebrain ischemia?
Topics: Animals; Arachidonic Acid; Cardiolipins; Cytidine Diphosphate Choline; Disease Models, Animal; Enzyme Activation; Fatty Acids; Gerbillinae; Hippocampus; Injections, Intraperitoneal; Ischemic Attack, Transient; Isoenzymes; Male; Nootropic Agents; Phosphatidylcholines; Phosphatidylinositols; Phospholipase D; Phospholipases; Phospholipases A; Prosencephalon; Type C Phospholipases | 2001 |
Effects of citicoline on phospholipid and glutathione levels in transient cerebral ischemia.
Topics: Animals; Cytidine Diphosphate Choline; Disease Models, Animal; Fatty Acids; Gerbillinae; Glutathione; Glutathione Reductase; Hippocampus; Ischemic Attack, Transient; Male; Phospholipids; Prosencephalon; Reperfusion | 2001 |
Phospholipid metabolism during renal regeneration after acute tubular necrosis.
Topics: Acute Kidney Injury; Animals; Blood Urea Nitrogen; Cell Membrane; Choline; Cytidine Diphosphate Choline; Disease Models, Animal; Kidney; Kidney Tubular Necrosis, Acute; Male; Mercury; Phosphatidylcholines; Phospholipids; Rats; Regeneration | 1977 |
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, Spinal; Humans; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pruritus; Receptors, Atrial Natriuretic Factor; Reproducibility of Results; Signal Transduction; Small Molecule Libraries | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |